Back to MGX
CITADEL ADVISORS LLC MGX Position History
Metagenomi Therapeutics, Inc.
Quarters held
13
Latest value
$21K
Q2 2026
Peak value
$7.5M
First seen
Q1 2024
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q1 2024 | $7.5M |
| Q2 2024 | $2.8M |
| Q2 2024 | $156K |
| Q3 2024 | $1.5M |
| Q3 2024 | $245K |
| Q4 2024 | $487K |
| Q4 2024 | $53K |
| Q2 2025 | $90K |
| Q4 2025 | $182K |
| Q4 2025 | $107K |
| Q1 2026 | $23K |
| Q2 2026 | $21K |
| Q2 2026 | $21K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q2 2026 | $21K | 17.9K | — | — |
| Q2 2026 | $21K | 17.9K | — | — |
| Q1 2026 | $23K | 17.0K | — | — |
| Q4 2025 | $107K | 65.8K | — | — |
| Q4 2025 | $182K | 112.4K | — | — |
| Q2 2025 | $90K | 60.6K | — | — |
| Q4 2024 | $53K | 14.7K | — | — |
| Q4 2024 | $487K | 135.0K | — | — |
| Q3 2024 | $245K | 112.9K | — | — |
| Q3 2024 | $1.5M | 691.5K | — | — |
| Q2 2024 | $156K | 38.3K | — | — |
| Q2 2024 | $2.8M | 691.5K | — | — |
| Q1 2024 | $7.5M | 723.9K | — | — |